TR199801574T2 - Mizolastin ihtiva eden yavas isletme farmakolojik formülleri. - Google Patents

Mizolastin ihtiva eden yavas isletme farmakolojik formülleri.

Info

Publication number
TR199801574T2
TR199801574T2 TR1998/01574T TR9801574T TR199801574T2 TR 199801574 T2 TR199801574 T2 TR 199801574T2 TR 1998/01574 T TR1998/01574 T TR 1998/01574T TR 9801574 T TR9801574 T TR 9801574T TR 199801574 T2 TR199801574 T2 TR 199801574T2
Authority
TR
Turkey
Prior art keywords
slow
formulas containing
pharmacological
mizolastine
acting pharmacological
Prior art date
Application number
TR1998/01574T
Other languages
English (en)
Inventor
Chariot Maryvonne
Lewis Gareth
Montel Jean
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of TR199801574T2 publication Critical patent/TR199801574T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Yagli bir matris ve organik bir asitle kombine olan mizolastini kapsayan ve kapli olan bir yavas birakma tabletinden olusan bir öz içermesiyle karakterize edilen ve mizolastin ihtiva eden bir yavas isletme farmakolojik formülü bildirilmektedir.
TR1998/01574T 1996-03-04 1997-02-28 Mizolastin ihtiva eden yavas isletme farmakolojik formülleri. TR199801574T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (1)

Publication Number Publication Date
TR199801574T2 true TR199801574T2 (tr) 1998-11-23

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01574T TR199801574T2 (tr) 1996-03-04 1997-02-28 Mizolastin ihtiva eden yavas isletme farmakolojik formülleri.

Country Status (35)

Country Link
US (2) US6165507A (tr)
EP (1) EP0906101B1 (tr)
JP (2) JP2000512617A (tr)
KR (1) KR100369888B1 (tr)
CN (1) CN1112929C (tr)
AR (1) AR006082A1 (tr)
AT (1) ATE219365T1 (tr)
AU (1) AU725494B2 (tr)
BG (1) BG63451B1 (tr)
BR (1) BR9707827A (tr)
CA (1) CA2247405C (tr)
CO (1) CO4780020A1 (tr)
CY (1) CY2293B1 (tr)
CZ (1) CZ291418B6 (tr)
DE (1) DE69713505T2 (tr)
DK (1) DK0906101T3 (tr)
EE (1) EE03511B1 (tr)
ES (1) ES2177942T3 (tr)
FR (1) FR2745500B1 (tr)
HK (1) HK1017999A1 (tr)
HU (1) HU227472B1 (tr)
IL (1) IL126050A (tr)
IN (1) IN187739B (tr)
NO (1) NO315841B1 (tr)
NZ (1) NZ331947A (tr)
OA (1) OA10854A (tr)
PL (1) PL189813B1 (tr)
PT (1) PT906101E (tr)
RU (1) RU2173997C2 (tr)
SK (1) SK282112B6 (tr)
TR (1) TR199801574T2 (tr)
TW (1) TW491711B (tr)
UA (1) UA49004C2 (tr)
WO (1) WO1997032584A1 (tr)
ZA (1) ZA971830B (tr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
EP1322158B1 (en) * 2000-10-02 2012-08-08 USV Ltd. Sustained release pharmaceutical compositions containing metformin and method of their production
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
NZ542176A (en) * 2003-03-04 2007-12-21 Nostrum Pharmaceuticals Inc Control release formulation containing a hydrophobic material as the sustained release agent
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
EP2309985B1 (en) 2008-07-28 2018-03-14 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
HUP9902458A3 (en) 2002-11-28
ATE219365T1 (de) 2002-07-15
DE69713505T2 (de) 2003-02-13
CO4780020A1 (es) 1999-05-26
CA2247405C (en) 2004-04-20
WO1997032584A1 (fr) 1997-09-12
PL328763A1 (en) 1999-02-15
NZ331947A (en) 2000-03-27
JP2007182451A (ja) 2007-07-19
EP0906101B1 (fr) 2002-06-19
NO984035D0 (no) 1998-09-02
AU725494B2 (en) 2000-10-12
HUP9902458A2 (hu) 2000-05-28
FR2745500B1 (fr) 1998-04-03
SK282112B6 (sk) 2001-11-06
KR19990087387A (ko) 1999-12-27
BG102692A (en) 1999-04-30
IL126050A0 (en) 1999-05-09
CY2293B1 (en) 2003-07-04
EE03511B1 (et) 2001-10-15
TW491711B (en) 2002-06-21
NO984035L (no) 1998-10-22
AR006082A1 (es) 1999-08-11
UA49004C2 (uk) 2002-09-16
PL189813B1 (pl) 2005-09-30
IL126050A (en) 2004-05-12
HK1017999A1 (en) 1999-12-10
CA2247405A1 (en) 1997-09-12
AU1930097A (en) 1997-09-22
ES2177942T3 (es) 2002-12-16
DE69713505D1 (de) 2002-07-25
ZA971830B (en) 1997-09-04
FR2745500A1 (fr) 1997-09-05
DK0906101T3 (da) 2002-10-14
JP2000512617A (ja) 2000-09-26
SK121098A3 (en) 1999-01-11
PT906101E (pt) 2002-09-30
OA10854A (fr) 2003-02-05
RU2173997C2 (ru) 2001-09-27
US20050202089A1 (en) 2005-09-15
EP0906101A1 (fr) 1999-04-07
BR9707827A (pt) 1999-07-27
CN1212624A (zh) 1999-03-31
HU227472B1 (en) 2011-07-28
NO315841B1 (no) 2003-11-03
CN1112929C (zh) 2003-07-02
IN187739B (tr) 2002-06-15
EE9800275A (et) 1999-02-15
US6165507A (en) 2000-12-26
BG63451B1 (bg) 2002-02-28
CZ291418B6 (cs) 2003-03-12
KR100369888B1 (ko) 2003-05-17
CZ279198A3 (cs) 1999-01-13

Similar Documents

Publication Publication Date Title
AR006390A1 (es) Derivados de lactama
TR200100623T2 (tr) 5-Tia-w-ikameli fenil-prostaglandin türevleri, bunları üretme yöntemleri ve müessir madde olarak bunları ihtiva eden ilaçlar
ES2195970T3 (es) L-ribavirina y usos de la misma.
BR9106405A (pt) Circuidade de controle de energia,telefone celular de acesso multiplo de divisao de tempo
PA8423701A1 (es) Nuevos plaguicidas
TR200200460T2 (tr) Yeni fenilpiperazinler
TR199801574T2 (tr) Mizolastin ihtiva eden yavas isletme farmakolojik formülleri.
BR0115701A (pt) Suprimento de energia
BRPI0512310A (pt) compostos quìmicos
NO864431D0 (no) Elektrisk koplingsorgan, saerlig koplingsorgan som er fluidumstette ved nedsenking i en vaeske.
GT199900173A (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida.
TR200000006T2 (tr) Yeni formülasyon.
ES2155442T3 (es) Un derivado de oxazolina, su produccion y su uso.
NO20012817L (no) Fenetyl-5-brompyridyltiourea (PBT) og dihydroalkoksybenzyloksopyrimidin (DABO) derivater som utoverspermicidal aktivitet
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
TR200001121T2 (tr) Antiromatizmal madde.
BR9914688A (pt) Compostos de pirano, piperidino e tiopirano e seus métodos de uso
AR002668A1 (es) Derivados de bis-oxima un procedimiento para su manufactura composición que los contiene y su uso para el control de microorganismos insectos y acaros
PA8504601A1 (es) Procedimiento para la preparación de compuestos de pirazolo [4,3-d] pirimidin-7-onas-3-piridilsulfonilo e intermedios de los mismo.
AR005704A1 (es) Heteroariloxazolidinonas
SV2002000302A (es) Nuevos derivados de amidas heterociclicas ref. pc 10561/20140/bb
AR220313A1 (es) Procedimiento para obtener un gas industrial que contiene metano e hidrogeno a partir de desechos,basuras domiciliarias y otros residuos organicos
TR200003351T2 (tr) Paroksetin içeren yeni formülasyon
FI971587A (fi) Solmuryhmien käyttö sijaintitietona